[PHARMA] YoY TTM Result on 30-Jun-2009 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Aug-2009
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2009
Quarter
30-Jun-2009 [#2]
Profit Trend
QoQ- 8.2%
YoY- -12.21%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Revenue 1,642,700 1,492,216 1,321,763 1,289,459 1,290,632 1,112,447 967,662 9.21%
PBT 102,587 53,876 69,675 86,658 103,949 32,429 26,688 25.13%
Tax -34,308 -17,749 -17,335 -24,472 -33,502 -16,635 -6,615 31.53%
NP 68,279 36,127 52,340 62,186 70,447 15,794 20,073 22.61%
-
NP to SH 67,151 35,734 52,027 60,598 69,023 14,068 18,614 23.81%
-
Tax Rate 33.44% 32.94% 24.88% 28.24% 32.23% 51.30% 24.79% -
Total Cost 1,574,421 1,456,089 1,269,423 1,227,273 1,220,185 1,096,653 947,589 8.82%
-
Net Worth 481,394 451,517 417,065 400,161 362,716 314,357 316,871 7.21%
Dividend
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Div 52,948 - 118,755 57,770 38,516 16,038 15,951 22.11%
Div Payout % 78.85% - 228.26% 95.33% 55.80% 114.01% 85.70% -
Equity
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Net Worth 481,394 451,517 417,065 400,161 362,716 314,357 316,871 7.21%
NOSH 117,700 106,994 106,939 106,995 106,995 106,924 107,051 1.59%
Ratio Analysis
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
NP Margin 4.16% 2.42% 3.96% 4.82% 5.46% 1.42% 2.07% -
ROE 13.95% 7.91% 12.47% 15.14% 19.03% 4.48% 5.87% -
Per Share
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
RPS 1,395.66 1,394.66 1,235.99 1,205.16 1,206.24 1,040.41 903.93 7.50%
EPS 57.05 33.40 48.65 56.64 64.51 13.16 17.39 21.87%
DPS 44.99 0.00 111.00 54.00 36.00 15.00 14.90 20.20%
NAPS 4.09 4.22 3.90 3.74 3.39 2.94 2.96 5.53%
Adjusted Per Share Value based on latest NOSH - 106,995
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
RPS 113.98 103.54 91.71 89.47 89.55 77.19 67.14 9.21%
EPS 4.66 2.48 3.61 4.20 4.79 0.98 1.29 23.84%
DPS 3.67 0.00 8.24 4.01 2.67 1.11 1.11 22.03%
NAPS 0.334 0.3133 0.2894 0.2777 0.2517 0.2181 0.2199 7.20%
Price Multiplier on Financial Quarter End Date
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Date 29/06/12 30/06/11 30/06/10 30/06/09 30/06/08 29/06/07 30/06/06 -
Price 10.18 5.90 4.98 3.80 3.27 3.53 4.51 -
P/RPS 0.73 0.42 0.40 0.32 0.27 0.34 0.50 6.50%
P/EPS 17.84 17.67 10.24 6.71 5.07 26.83 25.94 -6.04%
EY 5.60 5.66 9.77 14.90 19.73 3.73 3.86 6.39%
DY 4.42 0.00 22.29 14.21 11.01 4.25 3.30 4.98%
P/NAPS 2.49 1.40 1.28 1.02 0.96 1.20 1.52 8.56%
Price Multiplier on Announcement Date
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Date 08/08/12 10/08/11 11/08/10 21/08/09 14/08/08 17/08/07 16/08/06 -
Price 8.83 5.90 4.95 4.00 3.44 3.44 4.00 -
P/RPS 0.63 0.42 0.40 0.33 0.29 0.33 0.44 6.15%
P/EPS 15.48 17.67 10.17 7.06 5.33 26.15 23.00 -6.38%
EY 6.46 5.66 9.83 14.16 18.75 3.82 4.35 6.80%
DY 5.09 0.00 22.42 13.50 10.47 4.36 3.73 5.31%
P/NAPS 2.16 1.40 1.27 1.07 1.01 1.17 1.35 8.14%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment